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Abstract
We report a case of a female patient who was operated at the third relapse of an atrial myxoma caused by Carney
complex. The difficult operation was performed without any complications despite extensive adhesions caused by
the previous operations. The further inpatient course went without complications and the patient was discharged
to the consecutive treatment on the 9th postoperative day. The echocardiographic finding postoperative showed
no abnormalities.
Case report
In 1998 a 45 year old female patient presented with com-
plete left sided hemiparesis after a cerebral embolism.
While focusing on the reason for this clinical presenta-
tion a large mass lesion was found in the atrium via echo-
cardiography whereby suspicion of atrial myxoma was
raised. The patient was referred to our department and
operative resection of the large myxoma was performed
which was predominant prolapsed into the left ventricle
at the distal roof of the left atrium above the mitral valve.
Both intraoperative and inpatient course progressed
without complications and the patient was rapidly dis-
charge for early neurological rehabilitation.
Three years later, a left atrial tumor was seen in a rou-
tine cardiological echocardiography follow up and the
suspicion of a relapse of the atrial myxoma was raised.
A resection of the two-hazelnut-sized myxoma at the
posterior wall of the left atrium was performed again.
The operation and inpatient course again proceeded
without complications and the patient was rapidly dis-
charged again.
After a period of four years an echopenic structure
with freely moving component parts was found at the
left side during a transesophageal echocardiography and
the suspicion of a second relapse was raised. Making
additionally there were found sutures of the previous
operations at the septum. But making a clear
differentiation between a thrombus at the previous
suture line and a myxoma relapse was not possible;
therefore a three months oral anticoagulation with
phenprocoumon was started.
With a positive family history for myxomas (the
patients’s brother and grandfather) and multiple lenti-
gines an evaluation of the presence of Carney complex,
an autosomal dominant disorder, was conducted. After
genetic analysis the diagnosis of Carney complex type I
with a deletion mutation in the PRKAR1A gene was
detected. Carney complex type I is characterized by
recurrent atrial myxomas, skin, conjunctiva and lips len-
tigines, subclinical hypercortisolism and nodular thyroid
changes.
After three months of effective oral anticoagulation the
structure at the atrial septum was not increased in size. A
conservative approach was agreed while maintaining oral
anticoagulation and regular echocardiographic follow up.
Three years later an echocardiographic study revealed a
new tumor, however this time the location was the right
atrium. The left sided structure was unchanged. An
operative resection was carried out again via re-sternot-
omy with an oscillating saw after preoperative evaluation
(computed tomography (CT) scan of the thorax, trans-
thoracic doppler echocardiogram, doppler examination
of the femoral vessels, and lower limb arteries). The car-
diopulmonary bypass with systemic 32°C mild hypother-
mia was established via ascending aortic and bicaval
cannulation. The right atrial tumor (approximately 3 cm
in diameter) was located at the confluence of inferior
vena cava and the lateral atrial wall. An atrial myxoma
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any medium, provided the original work is properly cited.was confirmed histologically with a tumour-free resection
margin. The postoperative course was again without
complication. During the last echocardiographic follow
up a progressive left atrial structure was seen and the
decision was made to resect the fourth atrial myxoma
(Figure 1). Again the postoperative course went without
complications.
Discussion
As with every other organ the heart can be affected by
tumor and its relapses. Primary tumors of the heart are
rare. The incidence varies between 0.0017 and 0.19% in
unselected autopsy studies. Three quarters of primary
heart tumors are benign and half of them are atrial
myxomas. Other benign tumors are lipoma, papillary
fibroelastoma, rhabdomyoma and fibroma [1,2].
Myxomas are mesenchymal tumors, which can occur
at any age, however, they mainly exist between the 30th
and 60th year of life. This disease is approximately two
to three times more prevalent in women than in men
[1-3]. About 75% of the myxomas are located in the left
atrium, 20% in the right atrium and 5% in one of the
ventricles. Multiple tumors in different ventricles have
been described in a few patients [1,3]. Myxomas are
typically sporadic and isolated, only in around five per-
cent of all cases this disease occurs as a familial disease
[1]. This group of patients are younger, frequently have
multifocal tumors, but, there is no gender preference.
Because every fifth patient suffers from additional neo-
plasms this disease pattern is also called ‘complex myx-
oma’ or Carney complex [1,4,5]. Most of the myxomas
are pedunculated (seldom broad based) and are often
located in the area of fossa ovalis, but they can also
occur anywhere in the atrial wall, the vena cava or rarely
at the heart valves [1-3]. The tumor’s mobility depends
mostly on the length of the tumor stem. The clinical
picture is determined by localization, dimension, condi-
tion and tumor mobility [1,2]. Characteristically, the
period until the diagnosis is made is highly variable,
because the time free of symptoms can be quite long.
Usually a local complication leads to symptoms and this
requires further diagnostic tests. Most common compli-
cations are embolism (about 30-40%, both peripheral
and central, whereas central embolisms are more fre-
quent), intra cardiac obstruction and obstruction of the
ventricular outflow tract (seen in left or right heart fail-
ure with symptoms of dyspnoea, syncope, supra ventri-
cular cardiac arrhythmia). Another common
complication is the so called ‘myxoma disease’ with
fever, arthralgies, polymyositis, weight loss and hyper-
gammaglobulinaemia [1-3,6].
The clinical examination, chest X-ray and ECG are
inefficient and non-specific. Often the diagnosis is an
incidental finding detected by echocardiography mea-
surements in the context of peripheral tumor emboli
diagnosis. However, transthoracic or transesophageal
echocardiography can show exactly the tumor’s position
and dimension, alternatives are cardiac CT and cardiac
MRI. Differential diagnosis to consider is always a
thrombus giving the same clinical picture. The preferred
treatment is always surgical removal indicating a cura-
tive approach. Both short- and long-term results are
excellent [1-3].
An operation is always indicated because the outcome
and clinical course without intervention cannot be pre-
dicted. Due to the high rate for embolisms and the dan-
ger of the sudden cardiac death the operation should be
performed as soon as possible following diagnosis [1-3].
The risk of a myxoma relapse is well documented in the
literature. Reasons for relapses are: inadequate resec-
tions, intraoperative implantation of parts of the tumor
and multi-located tumor origin. The relapse risk for
sporadically occurring myxomas varies between 1 and
3% and it is increased significantly for patients with
familial aggregation or Carney complex [1,3,7]. The Car-
ney complex (CNC) is an autosomal dominant inherita-
ble disease characterized by myxomas, schwannomas,
germ cell tumors, abnormal skin pigmentation and
endocrine hyperactivity. The average age at the time of
diagnosis is around the age of 20 [4,8-10]. There is no
gender-related difference and the Carney complex can
occur in all races. In 50% of the patients there is a
mutation in the PRKAR1A gene on chromosome 17
(type I or CNC1). This gene codes for the regulatory
subunit type 1A of protein kinase A, that plays an
important role in different endocrine signaling cascades
and also as a tumor suppressor gene. A mutation on
chromosome 2 probably codes for a, so far, not charac-
terized variation of the Carney complex (type II of
CNC2) [8,10]. The life expectancy for patients with Car-
ney complex is reduced. Most of the patients die from
complications of cardiac myxomas, metastasizing or
Figure 1 Intraoperative finding of the resected myxoma.
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thyroid carcinomas and metastasising pancreatic or
germ cell tumors [8]. Hence, close monitoring is neces-
sary for patients with Carney complex and their blood
relations. With an additional genetic analysis the diagno-
sis of Carney complex was made for our patient.
As with sporadically occurring myxomas a resection of
the cardiac tumor and its relapses should be performed
in patients with Carney complex. Serious surgical pro-
blems are especially peri- and epicardiac adhesions from
previous operations which increase after every relapse
resection. This can lead to a situation where the surgical
risk is higher than the risk of death due to complica-
tions of the myxoma. Therefore a careful consideration
of the complication-benefit analysis should be made
especially for patients with Carney complex. In indivi-
dual cases a non-operative approach has been described
[7]. In the event of the second relapse we also recom-
mended a non-operative approach combined with con-
tinued anticoagulation as prophylaxis against apposition
thrombi and careful clinical examination. Our reasoning
consisted of the two previously performed operations
were the dimension, localization and morphology of the
tumor relapse. However, due to the increase in the
dimension of the lesion and appearance of cardiac
symptoms we decided to resect the myxoma relapse for
a fourth time.
Normally echocardiographic follow up should be per-
formed each year to detect myxoma relapses early.
Patients with known Carney complex should have this
examination every six month if they have already had a
surgical resection [8,9]. After the fourth operation due
to the third myxoma relapse we considered platelet
aggregation inhibition for our patient as a treatment to
prevent complications associated with emboli as
sufficient.
Conclusion
The Carney complex is an infrequent congenital disease
where the relapse rate of cardiac myxomas is manifestly
increased. With close follow up with echocardiography
relapses can be detected early and adequately treated.
Concerning postoperative anticoagulation we considered
it appropriate that our patient received a platelet aggre-
gation inhibitor in light of present of inconspicuous
echocardiographic findings.
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